These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23963599)

  • 21. Revascularization options in stable coronary artery disease: it is not how to revascularize, it is whether and when to revascularize.
    Torosoff MT; Sidhu MS; Desai KP; Fein SA; Boden WE
    J Comp Eff Res; 2015 Sep; 4(5):505-14. PubMed ID: 26387530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Revascularization strategies in patients with diabetes and stable ischemic heart disease: a systematic review and meta-analysis of randomized trials.
    Noguchi M; Ueyama H; Fujisaki T; Takagi H; Kuno T
    J Cardiovasc Med (Hagerstown); 2022 Apr; 23(4):242-246. PubMed ID: 35029867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Percutaneous coronary intervention for the management of stable ischemic heart disease.
    Liu S; Tsang M; Abdel-Qadir H; Yanagawa B; Bagai A
    Curr Opin Cardiol; 2019 Sep; 34(5):557-563. PubMed ID: 31246588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Revascularization versus medical therapy in patients aged 80 and older with stable ischemic heart disease.
    Phan DQ; Zadegan R; Lee MS
    J Am Geriatr Soc; 2021 Dec; 69(12):3457-3467. PubMed ID: 34363216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ischemia Trial: Does the Cardiology Community Need to Pivot or Continue Current Practices?
    Jafary FH; Jafary AH
    Curr Cardiol Rep; 2022 Aug; 24(8):1059-1068. PubMed ID: 35653055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kidney function modifies the selection of treatment strategies and long-term survival in stable ischaemic heart disease: insights from the Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease (APPROACH) registry.
    Shavadia JS; Southern DA; James MT; Welsh RC; Bainey KR
    Eur Heart J Qual Care Clin Outcomes; 2018 Oct; 4(4):274-282. PubMed ID: 29106471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Ischemic cardiomyopathy: possibilities of surgical treatment].
    Benetis R; Simukauskiene A; Jankauskiene L; Kavoliūniene A
    Medicina (Kaunas); 2007; 43(11):909-17. PubMed ID: 18084150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease : A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons.
    Patel MR; Calhoon JH; Dehmer GJ; Grantham JA; Maddox TM; Maron DJ; Smith PK
    J Nucl Cardiol; 2017 Oct; 24(5):1759-1792. PubMed ID: 28608183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized Comparison of Clinical Effectiveness of Pharmacologic SPECT and PET MPI in Symptomatic CAD Patients.
    Patel KK; Al Badarin F; Chan PS; Spertus JA; Courter S; Kennedy KF; Case JA; McGhie AI; Heller GV; Bateman TM
    JACC Cardiovasc Imaging; 2019 Sep; 12(9):1821-1831. PubMed ID: 31326480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of Outcomes of Invasive or Conservative Management of Chronic Coronary Disease in Four Randomized Controlled Trials.
    Mavromatis K; Boden WE; Maron DJ; Mancini GBJ; Weintraub WS; Gosselin G; Berman DS; Shaw LJ; Spertus JA; Hochman JS
    Am J Cardiol; 2022 Dec; 185():18-28. PubMed ID: 36257844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fractional flow reserve and myocardial perfusion imaging in patients with angiographic multivessel coronary artery disease.
    Melikian N; De Bondt P; Tonino P; De Winter O; Wyffels E; Bartunek J; Heyndrickx GR; Fearon WF; Pijls NH; Wijns W; De Bruyne B
    JACC Cardiovasc Interv; 2010 Mar; 3(3):307-14. PubMed ID: 20298990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and Rationale of the RIPCORD 2 Trial (Does Routine Pressure Wire Assessment Influence Management Strategy at Coronary Angiography for Diagnosis of Chest Pain?): A Randomized Controlled Trial to Compare Routine Pressure Wire Assessment With Conventional Angiography in the Management of Patients With Coronary Artery Disease.
    Elguindy M; Stables R; Nicholas Z; Kemp I; Curzen N
    Circ Cardiovasc Qual Outcomes; 2018 Feb; 11(2):e004191. PubMed ID: 29449442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can Functional Testing for Ischemia and Viability Guide Revascularization?
    Mielniczuk LM; Toth GG; Xie JX; De Bruyne B; Shaw LJ; Beanlands RS
    JACC Cardiovasc Imaging; 2017 Mar; 10(3):354-364. PubMed ID: 28279384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(16):1-167. PubMed ID: 23074467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fractional flow reserve-guided coronary bypass surgery: should surgeons use it?
    Ferguson TB; Chen C; Buch AN
    Curr Opin Cardiol; 2013 Nov; 28(6):654-60. PubMed ID: 24100651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical implications of the BARI 2D and COURAGE trials: overview.
    Brooks MM; Boden WE; Frye RL
    Coron Artery Dis; 2010 Nov; 21(7):383-5. PubMed ID: 20664331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utilization and Outcomes of Measuring Fractional Flow Reserve in Patients With Stable Ischemic Heart Disease.
    Parikh RV; Liu G; Plomondon ME; Sehested TSG; Hlatky MA; Waldo SW; Fearon WF
    J Am Coll Cardiol; 2020 Feb; 75(4):409-419. PubMed ID: 32000953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myocardial Ischemia in the Management of Chronic Coronary Artery Disease: Past and Present.
    Gibbons RJ
    Circ Cardiovasc Imaging; 2021 Jan; 14(1):e011615. PubMed ID: 33455408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Percutaneous coronary intervention outcomes in patients with stable obstructive coronary artery disease and myocardial ischemia: a collaborative meta-analysis of contemporary randomized clinical trials.
    Stergiopoulos K; Boden WE; Hartigan P; Möbius-Winkler S; Hambrecht R; Hueb W; Hardison RM; Abbott JD; Brown DL
    JAMA Intern Med; 2014 Feb; 174(2):232-40. PubMed ID: 24296791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Benefit of revascularization for stable ischaemic heart disease: the jury is still out.
    Fassa AA; Wijns W; Kolh P; Steg PG
    Eur Heart J; 2013 Jun; 34(21):1534-8. PubMed ID: 23360779
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.